Terms: = Ovarian cancer AND TOP1, RP3-511B24_2, 7150, ENSG00000198900, TOPI, P11387 AND Staging
1275 results:
1. Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
Shi S; Li W; Ni G; Ding J; Liu Y; Wu H; Zhang Z; Ding Z
BMC Womens Health; 2024 Apr; 24(1):247. PubMed ID: 38637800
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
[No Abstract] [Full Text] [Related]
3. Squamous cell carcinoma malignant transformation in mature cystic teratoma of the ovary: a case report and review of the literature.
Jafari-Nozad AM; Jahani N; Nazeri N
J Med Case Rep; 2024 Mar; 18(1):145. PubMed ID: 38523295
[TBL] [Abstract] [Full Text] [Related]
4. The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study.
Li N; Chen Q; Li B
Medicine (Baltimore); 2024 Mar; 103(11):e37465. PubMed ID: 38489719
[TBL] [Abstract] [Full Text] [Related]
5. The Role of Lymphovascular Space Invasion and Cytology in the Prognosis of Endometrial cancer.
Ozdemir CY; Arioz DT; Celik F; Cicekli N; Chkhikvadze M; Bilir F; Yılmaz S; Vatansever N
Discov Med; 2024 Feb; 36(181):366-371. PubMed ID: 38409841
[TBL] [Abstract] [Full Text] [Related]
6. Laparoscopic versus laparotomic surgical treatment in apparent stage I ovarian cancer: a multi-center retrospective cohort study.
Zhang J; Li M; Feng L; Zhai Y; Wang L; Chen Y
World J Surg Oncol; 2024 Feb; 22(1):62. PubMed ID: 38389046
[TBL] [Abstract] [Full Text] [Related]
7. The significance of lower uterine segment involvement in endometrial cancer.
Davidesko S; Meirovitz M; Shaco-Levy R; Yarza S; Samueli B; Kezerle Y; Kessous R
Eur J Surg Oncol; 2024 Mar; 50(3):108007. PubMed ID: 38382274
[TBL] [Abstract] [Full Text] [Related]
8. To study the expression of estrogen, progesterone receptor and p53 immunohistochemistry markers in subtyping endometrial carcinoma.
Yadav A; Sistla A; Swain M; Gowrishankar S; Padua M; Modi T; Himabindu R; Agarwal N; Kulkarni A; Bhandari T; Vudayaraju H; Chinnababu ; Reddy VA
Indian J Pathol Microbiol; 2024; 67(1):62-67. PubMed ID: 38358190
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological pattern of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 over-expression of epithelial ovarian carcinomas in Nigeria.
Ajani MA; Lawan A; Oke T; Khramtsova G; Nwanji I; Salami A; Awolude O; Ebili H; Onwukamuche ME; Sveen E; Yoshimatsu T; Olopade OI
Afr Health Sci; 2023 Sep; 23(3):236-244. PubMed ID: 38357171
[TBL] [Abstract] [Full Text] [Related]
10. Is minimally invasive surgical approach a reasonable option in apparent early stage epithelial ovarian cancer restaging? Results from a multicentric retrospective study.
Mokarram Dorri N; Del M; Cannone F; Lefebvre M; Loaec C; Sabiani L; Jauffret C; Blache G; Houvenaeghel G; Carcopino X; Classe JM; Narducci F; Martinez A; Lambaudie E
Eur J Surg Oncol; 2024 Mar; 50(3):107976. PubMed ID: 38354484
[TBL] [Abstract] [Full Text] [Related]
11. Nuclear Medicine and Molecular Imaging Applications in Gynecologic Malignancies: A Comprehensive Review.
Khessib T; Jha P; Davidzon GA; Iagaru A; Shah J
Semin Nucl Med; 2024 Mar; 54(2):270-292. PubMed ID: 38342655
[TBL] [Abstract] [Full Text] [Related]
12. BRCA1, BRCA2, and TP53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer.
Richau CS; Scherer NM; Matta BP; de Armas EM; de Barros Moreira FC; Bergmann A; Pereira Chaves CB; Boroni M; Dos Santos ACE; Moreira MAM
Cancer Med; 2024 Feb; 13(3):e6729. PubMed ID: 38308422
[TBL] [Abstract] [Full Text] [Related]
13. Counselling Framework for Germline
Wong SM; Apostolova C; Eisenberg E; Foulkes WD
Curr Oncol; 2024 Jan; 31(1):350-365. PubMed ID: 38248108
[TBL] [Abstract] [Full Text] [Related]
14. Is routine gastrointestinal endoscopy required in every woman with mucinous ovarian cancer? An analysis of survival rates and metastatic tumours in a cancer centre.
Katsanevakis E; Addo-Yobo W; Bharathan B; Loona A; Gan C; Nunns D; Gajjar K
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():105-110. PubMed ID: 38237307
[TBL] [Abstract] [Full Text] [Related]
15. Survival outcomes of epithelial ovarian cancer treated at a tertiary-level hospital in India.
Chandy RG; Thomas V; Sebastian A; Mani T; Thomas A; Joel A; Ram TS; Peedicayil A
Indian J Cancer; 2023 Oct; 60(4):475-485. PubMed ID: 38185864
[TBL] [Abstract] [Full Text] [Related]
16. Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs.
Vasta FM; Cormio G; Cassani C; Bergamini A; Scarfone G; Ferrandina G; De Vivo R; Marinaccio M; Danese S; Raspagliesi F; Pignata S; Mangili G
Gynecol Oncol; 2024 Feb; 181():28-32. PubMed ID: 38104526
[TBL] [Abstract] [Full Text] [Related]
17. Ultrasound for assessing tumor spread in ovarian cancer. A systematic review of the literature and meta-analysis.
Luis Alcázar J; Ramón Pérez-Vidal J; Tameish S; Chacón E; Manzour N; Ángel Mínguez J
Eur J Obstet Gynecol Reprod Biol; 2024 Jan; 292():194-200. PubMed ID: 38042117
[TBL] [Abstract] [Full Text] [Related]
18. Critical elements in the operative management of pediatric malignant ovarian germ cell tumors.
Weil BR; Rich BS; Madenci AL; Stambough KC; Schmoke N; Peace A; Bruny JL; Rescorla FJ; Dicken BJ; Dietrich JE; Billmire DF
Semin Pediatr Surg; 2023 Oct; 32(5):151342. PubMed ID: 38039829
[TBL] [Abstract] [Full Text] [Related]
19. Effects of epidural anesthesia on the prognosis of ovarian cancer-a systematic review and meta-analysis.
Shen H; Pang Q; Gao Y; Liu H
BMC Anesthesiol; 2023 Nov; 23(1):390. PubMed ID: 38030996
[TBL] [Abstract] [Full Text] [Related]
20. Early-stage serous fallopian tube carcinoma.
Khromchenko K; Aikman N; Sun X; ElSahwi K
BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37996138
[TBL] [Abstract] [Full Text] [Related]
[Next]
